Practitioner Information

About Exacta

exacta® is a comprehensive in depth tumour gene expression analysis. It analyses 100’s of millions of data points at the molecular level to reveal all possible targets for precision drugs.

exacta® helps unravel the driver mutations and pathways that are propelling a particular person’s cancer through multi-analyte and multi-coordinate analysis over 20.805 genes in the cancer genome. This analysis helps identify targeted drugs that would be most effective for a particular cancer.

exacta®, thus enables a highly sophisticated treatment strategy beyond conventional perspective, even for difficult cancers.

exacta® is particularly recommended for cancer patients where ...

exacta® is performed by Datar Cancer Genetics. Datar Cancer Genetics is a World-leading molecular oncology facility with a fully equipped laboratory, integrated process platforms, in-house bioinformatics team, and a huge genetic data base for precise and updated reporting.

Please see Publications for Case Studies and Sample Reports.

For more information

Genostics Australia is the distributor for exacta® by Datar Cancer Genetics in Australia and New Zealand.

For more information including request forms, or to find out how to order a test, please call Genostics on +61 1300 282 482 or submit an online enquiry here.